TRTürkçe
ENEnglish
AZAzərbaycanca
UZO‘zbekcha
ARالعربية
FRFrançais
DEDeutsch
RUРусский
Medical Device CE Certification and Medical Device Legislation
Medical-device conformity starts with the actual intended purpose and manufacturer, then classification and the applicable assessment route. Build evidence for the device actually sold; Kayra can support preparation within its contract, while manufacturer duties and any required notified-body decision remain separate.
Intended purpose and justified classification
Identify the actual manufacturer, device models, intended purpose, users, patient population, use duration and contact with the body. Keep the label, instructions, promotional claims and clinical evaluation consistent. Apply MDR scope and Annex VIII classification to these real characteristics; a commercial device name or the requested certificate price cannot determine its class.
For example, an existing file describes one patient population, but the new label claims use for another. Compare instructions, promotional statements, clinical evaluation and risk analysis before retaining the old classification or evidence rationale. A proposed marketing sentence cannot silently extend a device’s assessed purpose; identify the gap and resolve it before treating the application as complete.
Choose the actual Article 52 route
Document the rule and its rationale before choosing the conformity assessment route. Distinguish ordinary Class I manufacturer declaration from the limited notified-body involvement for sterile, measuring or reusable surgical Class I devices and the relevant routes for other classes. Do not assign a class or exemption merely from resemblance to another product.
Select a notified body only where the actual procedure requires it, and verify the current designation and relevant device/activity scope. A familiar logo, ISO certificate or commercial offer does not establish MDR designation. Clarify the proposed assessment scope with the body; the consultant cannot choose an easier class to avoid required assessment or promise acceptance.
Evidence must cover the changed model
Map the applicable general safety and performance requirements, or GSPR, to controlled design, risk, verification, validation and clinical-evaluation evidence. Explain nonapplicable requirements. Link each report to its model, material, software version and configuration where relevant. A laboratory report or ISO 13485 certificate alone does not demonstrate all MDR duties or clinical performance.
Hypothetical example: a patient-contact component changes polymer, but the supplied biological report describes the old material. Compare composition, contact conditions and actual use; identify the unsupported conclusion and obtain justified technical review or additional evidence. Do not mark the gap closed because the two models share a trade name. Existing clinical literature also requires demonstrated relevance to the actual purpose.
Manufacturer, body and market outputs
The manufacturer maintains the technical documentation, risk and clinical evaluation, production controls, declarations and post-market processes. Where a notified body is required, verify its actual device/activity scope before application. Its assessment and certificate decision are distinct from Kayra’s contracted preparation; neither the consultant nor a general management-system certificate replaces that role.
Check the actual certificate, device scope, declaration and label before market use. UDI and EUDAMED registration are separate duties, not a substitute for conformity assessment or permission for another model. Review design, manufacturing and claim changes against the applicable route. CE for one assessed device does not approve every future variant or give blanket permission in every non-EU market.
Lifecycle and a defined preparation request
Provide manufacturer and sites, intended purpose, justified class, model and variant comparison, materials, software, manufacturing and available technical/clinical evidence. Identify whether the task is gap review, preparation, external testing or notified-body assessment. A quotation based only on the model count does not describe the actual work and decision dependencies.
Use separate milestones for scope and classification, complete documentation, implemented controls, necessary evidence generation, external assessment and responses to findings. Manufacturer readiness and body availability affect the sequence. Include ongoing post-market work and change control in the scope discussion; they are not completed by purchasing one certificate or entering a registration record.
Explore the subject
Use the guides to explore scope and practical questions in this field and find the detail relevant to your situation.
Tell us what you need and our specialists will contact you.
The exact records for Medical Device CE Certification and Medical Device Legislation depend on the confirmed scope. Current, consistent and traceable information reduces avoidable revisions.